Broker Tips
Broker tips: Spirent, Diageo, GlaxoSmithKline
Analysts at Barclays Research downgraded their view on shares of Spirent from 'equalweight' to 'underweight', telling clients that the stock's valuation was "out of sync" with testing peers.
Jefferies lowers Diageo to 'hold' following banner year
Analysts at Jefferies downgraded drinks maker Diageo from 'buy' to 'hold' on Thursday following "three very strong years of change" for the group.
Barclays downgrades Spirent on valuation after stellar run in 2019
Analysts at Barclays Research downgraded their view on shares of Spirent from 'equalweight' to 'underweight', telling clients that the stock's valuation was "out of sync" with testing peers.
Barclays downgrades GlaxoSmithKline to 'underweight'
Barclays downgraded its stance on GlaxoSmithKline shares to ‘underweight’ from ‘equalweight’ on Thursday, as it said 2020 looks set to be a much tougher investment year of little growth.